Abbvie

Forecast & Rating31 analysts currently cover Abbvie, with about 80.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $276.59, about 7.1% upside from the current price of $258.15. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 92.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Abbvie closely still see room for the stock to rise. Data as of Aug 26, 2026; for reference only and not investment advice.